These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31437373)

  • 1. Immunohistochemical analysis of Bcl-2, nuclear S100A4, MITF and Ki67 for risk stratification of early-stage melanoma - A combined IHC score for melanoma risk stratification.
    Jurmeister P; Bockmayr M; Treese C; Stein U; Lenze D; Jöhrens K; Friedling F; Dietel M; Klauschen F; Marsch W; Fiedler E; von Laffert M
    J Dtsch Dermatol Ges; 2019 Aug; 17(8):800-808. PubMed ID: 31437373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
    Naffouje S; Naffouje R; Bhagwandin S; Salti GI
    Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions.
    Nielsen PS; Riber-Hansen R; Steiniche T
    Am J Dermatopathol; 2011 Jun; 33(4):361-70. PubMed ID: 21610457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemically detectable bcl-2 expression in metastatic melanoma: association with survival and treatment response.
    Vlaykova T; Talve L; Hahka-Kemppinen M; Hernberg M; Muhonen T; Collan Y; Pyrhönen S
    Oncology; 2002; 62(3):259-68. PubMed ID: 12065874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma.
    Nielsen PS; Riber-Hansen R; Jensen TO; Schmidt H; Steiniche T
    Mod Pathol; 2013 Mar; 26(3):404-13. PubMed ID: 23174936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma.
    Zhuang L; Lee CS; Scolyer RA; McCarthy SW; Zhang XD; Thompson JF; Hersey P
    Mod Pathol; 2007 Apr; 20(4):416-26. PubMed ID: 17384650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD40, CD44, bcl-2 antigens and rate of cell proliferation on fine needle aspirates from metastatic melanoma.
    Sviatoha V; Rundgren A; Tani E; Hansson J; Kleina R; Skoog L
    Cytopathology; 2002 Feb; 13(1):11-21. PubMed ID: 11985564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma.
    Salti GI; Manougian T; Farolan M; Shilkaitis A; Majumdar D; Das Gupta TK
    Cancer Res; 2000 Sep; 60(18):5012-6. PubMed ID: 11016620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
    Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
    J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
    Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
    Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and Predictive Significance of Ki67 in Primary Non-metastatic or Recurrent Acral Melanoma: Evidence from a Multicenter Retrospective Study.
    Liang C; Li D; Liang Y; Xie Y; Lin N; Guan H; Hu W; Guan Y; Liang Y
    Ann Surg Oncol; 2024 Jul; 31(7):4594-4604. PubMed ID: 38689172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutated MITF-E87R in Melanoma Enhances Tumor Progression via S100A4.
    Nordlinger A; Dror S; Elkahloun A; Del Rio J; Stubbs E; Golan T; Malcov H; Pricket TD; Cronin JC; Parikh S; Labes S; Thomas L; Yankovitz G; Tabach Y; Levy C; Samuels Y; Khaled M
    J Invest Dermatol; 2018 Oct; 138(10):2216-2223. PubMed ID: 29679610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts.
    Meyer S; Fuchs TJ; Bosserhoff AK; Hofstädter F; Pauer A; Roth V; Buhmann JM; Moll I; Anagnostou N; Brandner JM; Ikenberg K; Moch H; Landthaler M; Vogt T; Wild PJ
    PLoS One; 2012; 7(6):e38222. PubMed ID: 22685558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
    Nazarian RM; Prieto VG; Elder DE; Duncan LM
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma.
    Nikkola J; Vihinen P; Vlaykova T; Hahka-Kemppinen M; Heino J; Pyrhönen S
    Melanoma Res; 2004 Feb; 14(1):29-37. PubMed ID: 15091191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of biomarkers in malignant melanoma.
    Hernberg M; Turunen JP; von Boguslawsky K; Muhonen T; Pyrhönen S
    Melanoma Res; 1998 Jun; 8(3):283-91. PubMed ID: 9664152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of thymidylate synthase (TS) expression in cutaneous malignant melanoma.
    Shimizu A; Kaira K; Yasuda M; Asao T; Ishikawa O
    Neoplasma; 2016; 63(2):282-7. PubMed ID: 26774151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 expression is not associated with survival in metastatic cutaneous melanoma: a historical cohort study.
    Espíndola MB; Corleta OC
    World J Surg Oncol; 2008 Jun; 6():65. PubMed ID: 18570663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel hypoxia-associated subset of FN1 high MITF low melanoma cells: identification, characterization, and prognostic value.
    Wouters J; Stas M; Govaere O; Barrette K; Dudek A; Vankelecom H; Haydu LE; Thompson JF; Scolyer RA; van den Oord JJ
    Mod Pathol; 2014 Aug; 27(8):1088-100. PubMed ID: 24390218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prognostic index in skin melanoma through the combination of matrix metalloproteinase-2, Ki67, and p53.
    Väisänen A; Kuvaja P; Kallioinen M; Turpeenniemi-Hujanen T
    Hum Pathol; 2011 Aug; 42(8):1103-11. PubMed ID: 21334717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.